Ortin Global
16.14
-0.06(-0.37%)
Market Cap₹13.10 Cr
PE Ratio-15.27
IndustryHealthcare
Company Performance:
1D-0.37%
1M-6.16%
6M+32.30%
1Y+36.55%
5Y-50.34%
View Company Insightsright
More news about Ortin Global
05Feb 26
Ortin Global Limited Schedules Board Meeting for February 14, 2026 to Review Q3FY26 Financial Results
Ortin Global Limited has scheduled a board meeting for February 14, 2026, to consider unaudited financial results for the quarter and nine months ended December 31, 2025. The meeting will be held at the company's registered office in Hyderabad in compliance with SEBI regulations. The company, formerly known as Ortin Laboratories Limited, has notified both BSE and NSE about this meeting as required under listing obligations.
 no imag found
02Aug 25
Ortin Global Limited Schedules EGM for Board Appointments and Remuneration Changes
Ortin Global, formerly Ortin Laboratories, has scheduled an EGM for August 25, 2025, to appoint new directors and make leadership changes. The company plans to appoint Mr. Sarang Balbhimrao Patodekar as Chairperson and Independent Director, along with Mr. Ajay Vishwakarma and Ms. Mounika Pammi as Independent Directors. Mr. Prashant Prakash Sawant and Mrs. Prakruti Prashant Sawant are proposed as Whole-time Directors with a monthly remuneration of Rs. 55,000 each. The pharmaceutical company reported a turnover of Rs. 602.03 lakhs for FY 2024-25 with a net loss of Rs. 9.36 lakhs. Remote e-voting will be available from August 22-24, 2025, with August 18, 2025, as the cut-off date for voting eligibility.
 no imag found
Ortin Global
16.14
-0.06
(-0.37%)
1 Year Returns:+36.55%
Industry Peers
Sun Pharmaceutical
1,794.40
(+0.63%)
Divis Laboratories
6,086.50
(+0.26%)
Torrent Pharmaceuticals
4,305.50
(+0.91%)
Dr Reddys Laboratories
1,283.80
(+0.54%)
Lupin
2,298.20
(+0.34%)
Cipla
1,281.90
(-1.39%)
Zydus Life Science
889.80
(+0.33%)
Mankind Pharma
2,068.20
(-1.27%)
Aurobindo Pharma
1,286.00
(+0.50%)
Alkem Laboratories
5,333.50
(+0.20%)